Stroke Prevention by ORal Thrombin Inhibition II "SPORTIF II"

Completed

Phase N/A Results

Summary of Purpose

To compare the tolerability and efficacy of ximelegatran with those of warfarin in preventing ischemic stroke in patients with non-valvular atrial fibrillation (NVAF).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, parallel-group trial.

Contacts

Not available